Biosergen publishes interim report for third quarter 2023
Thursday, November 30, 2023: Biosergen AB (“Biosergen” or the “Company”) hereby publishes the interim report for the third quarter 2023. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q3 2023 2023 2022 2023 2022 2022TSEK July-Sep July-Sep Jan-Sept Jan-Sep Jan-Dec Profit/loss Other income 292 493 8.063 3.219 5.183Profit/loss before -7.537 -14.515 -20.604 -27.496 -34.129depreciation